This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Lincoln University, The University of North Carolina at Chapel Hill. Active years: 2025.
Company Filing History:
1 out of 8 
1 out of 1,326 
Years Active: 2025
Title: David Palmer: Innovator in Genetic Research
Introduction
David Palmer is a notable inventor based in Christchurch, New Zealand. He has made significant contributions to the field of genetic research, particularly in the area of gene therapy. His work focuses on optimizing genetic sequences to address various disorders.
Latest Patents
David Palmer holds a patent for "Optimized CLN5 genes and expression cassettes and their use." This invention relates to polynucleotides comprising optimized CLN5 open reading frame (ORF) sequences, vectors that include these sequences, and methods for delivering the ORF to cells or subjects. The goal of this invention is to treat disorders associated with aberrant expression or activity of the CLN5 gene, such as CLN5 disease. He has 1 patent to his name.
Career Highlights
Throughout his career, David has worked with prestigious institutions, including the University of North Carolina at Chapel Hill and Lincoln University. His research has contributed to advancements in understanding genetic disorders and potential treatments.
Collaborations
David has collaborated with notable colleagues such as Steven Gray and Nadia Mitchell. Their combined expertise has furthered research in the field of genetic therapy.
Conclusion
David Palmer's innovative work in optimizing CLN5 genes showcases his commitment to advancing genetic research and developing potential treatments for genetic disorders. His contributions are significant in the ongoing quest to improve health outcomes for individuals affected by such conditions.